Heidi Cuthbert

Healthcare technology company Beamtree (ASX:BMT) announced CFO Michelle Spiller will resign effective July 24.

IREN raised its long-term annual revenue target for its artificial intelligence cloud business to more than US$4 billion, sending its shares up 16%.

QuickFee (ASX:QFE) reported fourth-quarter FY26 group revenue of $4.4 million, flat against normalised prior-period results.

Bernstein has increased its price target for Robinhood, pointing to the company's growing focus on tokenised assets and prediction markets.

Botala Energy (ASX:BTE) begins commercial production testing at its Pitse Pilot well 3.5B in Botswana.

MainStreet Bancshares (NASDAQ:MNSB) reported second-quarter 2026 net income of $4.7 million, driven by disciplined expense management and steady loan growth.

Dyne Therapeutics (NASDAQ:DYN) received FDA acceptance of its Biologics License Application for z-rostudirsen, an investigational treatment for Duchenne muscular dystrophy amenable to exon 51 skipping.

Boeing (NYSE:BA) and Philippine Airlines announced that the flag carrier has committed to order up to 20 Boeing 787 Dreamliner jets.

Greenwich LifeSciences (NASDAQ:GLSI) amended its Phase III breast cancer trial, expecting a 2.22x overall enrollment increase.

ING Groep (NYSE:ING) reported that Strait of Hormuz liquefied natural gas exports halted, driving regional prices up 25%.